Triomics

About Triomics

Triomics builds AI agents that turn unstructured oncology EHR data into structured, cited insights for clinical trial matching, visit preparation, and cancer registry curation at leading cancer centers.

Triomics builds task-driven AI agents that read entire oncology patient records—including pathology reports, clinical notes, genomic panels, and scanned faxes—and produce structured, cited outputs. The platform is designed for cancer centers and life sciences organizations, supporting workflows such as clinical trial matching, visit preparation, cancer registry curation, and quality reporting.

The company reports that 4 out of 10 top U.S. cancer centers trust its platform, which integrates with EMRs like Epic, OncoEMR, and iKnowMed. Customers use it to pre-screen patients for trials, reduce chart review time, and improve registry abstraction accuracy. Triomics has published results including increased trial accruals and reduced pre-charting time.

Triomics raised a $22M funding round and has been featured in coverage with institutions like MSK, Mount Sinai, and others. Its technology is built around OncoLLM, an LLM that reasons across the full patient chart, and is available on the Epic App Marketplace.